A Study to Evaluate MEDI5752 in Subjects with Advanced Solid Tumors
D7980C00001
Phase 1 other active
Quick answer
A Study to Evaluate MEDI5752 in Subjects with Advanced Solid Tumors for Advanced solid tumours is a Phase 1 program (other) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- Advanced solid tumours
- Phase
- Phase 1
- Modality
- other
- Status
- active